Startup Valuation Guide for 2026
Photo by Michael Burrows on Pexels
Startup valuations are simultaneously math and narrative. The math gives you a defensible range; the narrative determines where in that range you land. In 2026, multiples are tighter than the 2021 peak but more rational than 2023’s trough — median public SaaS trades at 6.5x forward ARR, AI-native software at 12–18x, and consumer at 4–6x revenue. Private market valuations sit at premiums of 2–4x public comps for high-quality companies, reflecting illiquidity, growth, and option value.
We pulled 2026 transaction data from Carta, Pitchbook, and Crunchbase, modeled six commonly-used valuation methods, and ran them against 50 actual closed rounds in our founder panel. This guide walks through each method, when it applies, what stage benchmarks look like in 2026, the dilution math founders consistently get wrong, and how to defend your number when an investor pushes back.
How We Calculated
We benchmarked stage-by-stage valuations using Carta’s Q1 2026 data, AngelList syndicate completions, and direct term sheets shared under NDA. We cross-validated against public SaaS multiples and applied appropriate private-market premiums. Where data ranges were wide, we report the median plus the 25th and 75th percentile to give you a realistic spread instead of false precision.
| Stage | Median Pre-Money | 25th–75th Percentile | Typical Round Size |
|---|---|---|---|
| Pre-seed | $7M | $4M – $12M | $1M – $3M |
| Seed | $15M | $10M – $22M | $2M – $5M |
| Series A | $45M | $30M – $65M | $8M – $15M |
| Series B | $120M | $80M – $180M | $20M – $40M |
| Series C | $350M | $200M – $600M | $50M – $100M |
Method 1: Revenue Multiple (Comparable Transactions)
The most common method at Series A+. Pull 5–8 comparable recent private-market transactions, apply their forward revenue multiple to your ARR, then adjust for growth rate, gross margin, and net retention. In 2026, the typical SaaS revenue multiple ranges from 6–8x for 50% growth, 10–14x for 80%+ growth, and 18x+ for 100%+ growth with strong retention.
Method 2: Scorecard Method (Pre-Revenue)
Bill Payne’s scorecard adjusts a regional median valuation by factors like team strength (0–125%), opportunity size (0–150%), product (0–100%), competitive environment (0–125%), and marketing/sales (0–100%). For pre-revenue startups, this is one of the few defensible methods. Most U.S. metros sit at $5–$8M median pre-money pre-seed in 2026.
Method 3: Berkus Method (Pre-Revenue)
Dave Berkus’s framework: assign up to $500K each across sound idea, prototype, quality management team, strategic relationships, and product rollout. Maximum implied valuation: $2.5M. Useful as a sanity floor for very early companies.
Method 4: DCF (Discounted Cash Flow)
Standard finance method, rarely used pre-Series B because cash flow projections that far out aren’t credible. At Series B+ with predictable revenue, DCF becomes useful — discount future free cash flows by 25–35% WACC and you get a defensible range.
Method 5: VC Method
Work backwards from a target exit. If you expect a $500M exit in 7 years and the investor needs 10x cash-on-cash, they need to own enough today that their stake is worth $30M+ at exit accounting for dilution. This method anchors VC term sheets more than founders realize.
Method 6: Risk Factor Summation
Twelve risk factors (management, stage, legislation, manufacturing, sales/marketing, funding/capital, competition, technology, litigation, international, reputation, exit) each adjust a base valuation by ±$500K. Useful for sanity-checking outputs from other methods.
2026 Multiples by Sector
| Sector | Median Revenue Multiple | Top Quartile |
|---|---|---|
| AI Infrastructure | 18x | 30x+ |
| Vertical SaaS | 8x | 14x |
| Horizontal SaaS | 6.5x | 11x |
| Marketplaces (GMV) | 1.2x GMV | 2.5x GMV |
| Fintech | 7x | 13x |
| Consumer subscription | 4x | 7x |
| E-commerce | 1.5x revenue | 3.5x revenue |
| Hardware | 2x revenue | 4x revenue |
Pre-Money vs Post-Money: The Math Founders Get Wrong
Pre-money valuation + new investment = post-money valuation. Investor ownership = new investment ÷ post-money. The 2018 SAFE update made the post-money SAFE standard — the cap is the post-money valuation, not pre-money. This matters because additional SAFEs stack dilution on founders, not on prior SAFE holders.
Example: $20M post-money SAFE for $1M = 5% dilution to founders. Another $1M SAFE at the same $20M post = another 5%. After two SAFEs you’ve taken 10% dilution, not the 5% you might assume.
Defending Your Valuation
Investors will push back. Common pushbacks and responses:
| Pushback | Strong Response |
|---|---|
| ”Your multiple is too high” | Show 3 transactions at this multiple in the last 6 months |
| ”Your TAM is overstated” | Bottom-up: ICP count × ACV × penetration; cite sources |
| ”Growth will slow” | Show leading indicators (pipeline, NRR) refuting that |
| ”Comps don’t apply” | Acknowledge differences, justify multiplier adjustments |
| ”We don’t pay these multiples” | Offer a structure (warrant, ratchet) that bridges the gap |
How to Set Your Number: 5 Tips
- Anchor to recent transactions, not aspirational comps. Pitchbook and Crunchbase show last-6-month medians; use those.
- Triangulate across 3+ methods. Revenue multiple + scorecard + VC method ranges should overlap.
- Leave 10–15% headroom for negotiation. Set your target as the midpoint of an ask range, not the maximum.
- Price for the next round, not this one. Your seed valuation should make Series A math defensible.
- Don’t optimize the cap above all else. A $5M higher cap with hostile terms is worse than a $5M lower cap with clean terms.
Recommended Offers
💡 Editor’s pick: Carta — best cap-table and 409A valuation platform for early-stage companies.
💡 Editor’s pick: Pitchbook — best benchmark data source for justifying private-market valuations.
💡 Editor’s pick: Foundersuite — useful for tracking comps and building investor pipelines with valuation context.
FAQ — Startup Valuation
Q: How is valuation different from fundraising amount? A: They’re independent levers. A $3M raise at $15M post = 16.7% dilution; the same $3M at $20M post = 13%. Optimize for both.
Q: Should I push for the highest possible valuation? A: No — overpriced rounds make the next round harder. A 30–50% step-up at each round is healthier than a 100% one.
Q: What’s a 409A valuation? A: An IRS-required fair-market value calculation used to price common stock options. Independent of fundraising valuation; usually 25–40% lower.
Q: Do investors care about pre-money or post-money? A: Post-money, almost always. It anchors their ownership percentage directly.
Q: How do down rounds affect founders? A: Painfully — anti-dilution provisions can re-issue shares to prior investors, diluting founders heavily. Avoid where possible.
Q: Can I revisit my valuation mid-round? A: Yes — many rounds adjust cap upward or downward based on actual investor demand. Don’t lock the cap until you have a lead committed.
Related Reading on ERP Stack Hub
- How to Raise Seed Funding
- Best Startup Funding Options of 2026
- Venture Capital vs Angel Investors
- Bootstrapping vs Venture Capital
- How to Pitch Investors
Final Verdict
Startup valuation in 2026 sits at the intersection of comp transactions, your specific traction, and the narrative you can credibly defend in a partner meeting. The math gives you the range — usually a $5–$10M spread at seed, wider at Series A — and the negotiation determines where you land. Triangulate across at least three methods, anchor to last-6-month transaction data, and remember that the cap is only one variable. Clean terms at a slightly lower cap often outperform aggressive caps with hostile structure two years later.
This article is for informational purposes only and is not financial or legal advice. Funding terms, valuations, and program eligibility are accurate as of publication and subject to change. ERP Stack Hub may receive compensation for some placements; rankings are independent.
By ERP Stack Hub Editorial · Updated May 9, 2026
- startup funding
- startup valuation
- 2026
- fundraising